CardioNet, headquartered in San Diego, became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet mobile cardiac outpatient telemetry (MCOT) system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients–at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia.
Recent NewsMore >>
DateTitle 
06/23/08CardioNet, Inc. Files Resale Registration Statement
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--June 23, 2008--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today filed a resale registration statement with the SEC related to the shares that were underlying the Mandatorily Redeemable Convertible Preferred Stock issued in March 2007. The shares being registered remain subject to lock-up agreements entered into in connection with CardioNet... 
Printer Friendly Version
05/19/08CardioNet, Inc. to Present at the 2008 Citi Investment Research Global Health Care Conference
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--May 19, 2008--CardioNet, Inc. (NASDAQ:BEAT) today announced that Arie Cohen, President and Chief Executive Officer, will present at the 2008 Citi Investment Research Global Health Care Conference on Wednesday, May 21, 2008 at 2:00 PM ET at the Hilton New York in New York, NY. You can access the presentation live by logging onto http://www.veracast.com/webcasts/citigroup/healthcare08/03112662.cfm . To ensure a timely connection, it is recommended... 
Printer Friendly Version
05/15/08CardioNet, Inc. Announces Amicable Resolution of Litigation
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--May 15, 2008--CardioNet, Inc. (NASDAQ:BEAT) announced today that LifeWatch Corp. and CardioNet have entered into a settlement agreement pursuant to which the parties have amicably agreed to resolve the lawsuit between them, with dismissal by both sides of all claims pending in the lawsuit. Terms of the agreement are confidential. Arie Cohen, President and Chief Executive Officer, commented: "We are pleased to have this behind us, and we look for... 
Printer Friendly Version
04/29/08CardioNet, Inc. Reports First Quarter 2008 Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--April 29, 2008--CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the quarter ended March 31, 2008. Q1 2008 Highlights Highlights of the first quarter of 2008 included: Reported Q1 2008 revenue growth of 67.9% compared to the same period last year adjusted to include the impact of the ... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


STOCK QUOTE
BEAT (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$27.36
Change (%) Stock is Up 0.48 (1.79%)
Volume17,654
Data as of 07/03/08
1:00 p.m. ET
Minimum 20 minute delay
Refresh quote

EMAIL ALERTS
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © CardioNet 2002-2008, All Rights Reservedprivacy policy/termssite mapinfo@cardionet.com